Veterinary Medicines

Gallivac IBD

Not authorised
  • Avian infectious bronchitis virus, Live
Download as PDF

Product identification

Medicine name:
Gallivac IBD
Active substance:
  • Avian infectious bronchitis virus, Live
Target species:
  • Chicken
Route of administration:
  • In drinking water use
  • Nasal use
  • Ocular use
  • Nebulisation use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, Live
    4.00
    log10 50% cell culture infectious dose
    /
    1.00
    dose
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        no withdrawal period
  • Nasal use
    • Chicken
      • Meat and offal
        no withdrawal period
  • Ocular use
    • Chicken
      • Meat and offal
        no withdrawal period
  • Nebulisation use
    • Chicken
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Netherlands B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 7907
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 31/08/2022
Download